Anonymized data from 803 older adult cancer patients receiving moderately- or highly-emetogenic chemotherapy. It includes sociodemographic and clinical characteristics alongside patient- and clinician-reported outcome measures of nausea and vomiting, collected at 24 hours and 5 days post-infusion as part of a longitudinal study.
Use Cases
- Analyze the relationship between patient sociodemographic characteristics and clinician-reported outcome measures of nausea and vomiting.
- Model the progression of patient-reported nausea outcomes from 24 hours to 5 days post-chemotherapy infusion.
- Examine associations between specific clinical characteristics and the severity of chemotherapy-induced vomiting reported by clinicians.
Strengths
- Data from 803 patient records provides a substantive sample for analysis.
- Includes both patient-reported and clinician-reported outcome measures for nausea and vomiting.
- Longitudinal design captures outcomes at two specific time points (24 hours and 5 days) post-treatment.
Limitations
- Sample size of 803 may limit statistical power for rare patient subgroups or outcomes.
- Lack of column details prevents assessment of data completeness and specific variable types.
- Focus on older adult patients may limit generalizability to younger cancer populations.
Provenance
- Source
- Aasha Hoogland Dataverse
- Collection Method
- Collected as part of a longitudinal study examining treatment effects of chemotherapy.
- Time Range
- null
- Freshness
- null
- Geography
- null